Minimum and optimal requirements for a safe clinical implementation of ultra-high dose rate radiotherapy: A focus on patient's safety and radiation protection

Affiliations

• ¹ IEO, Unit of Radiation Research, European Institute of Oncology IRCCS, 20141 Milan, Italy. Electronic address: [email protected].
• ² The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ³ Center for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland.
• ⁴ Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.
• ⁵ Division of Medical Physics, Department of Radiation Oncology, University Medical Center Freiburg, 79106, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
• ⁶ National Physical Laboratory, Medical Radiation Science, Teddington, UK.
• ⁷ Zuidwest Radiotherapeutisch Institute, Vlissingen, the Netherlands; Dept of Oncology, University of Oxford, Oxford, UK.
• ⁸ Iridium Netwerk, Antwerp University (Centre for Oncological Research, CORE), Antwerpen, Belgium; SCK CEN (Research in Dosimetric Applications), Mol, Belgium.
• ⁹ Iridium Netwerk, Antwerp University (Centre for Oncological Research, CORE), Antwerpen, Belgium.